ArticleBMC veterinary research2026
CRISPR/Cas12a-assisted visual and on-site detection of porcine circovirus type 2.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPorcine circovirus type 2 (PCV2) is a globally prevalent viral pathogen that causes substantial economic losses in the swine industry. Rapid and accurate on-site diagnosis is critical for controlling the spread of PCV2. In recent years, RNA-guided CRISPR/Cas12a nucleases combined with recombinase polymerase amplification (RPA) have emerged as a promising approach for nucleic acid detection. This study aimed to develop a novel RPA-CRISPR-based method for the rapid and sensitive detection of PCV2 in field settings.
resultsWe designed and optimized CRISPR RNAs (crRNAs) targeting conserved regions of the PCV2 Cap and Rep genes. Upon recognition of the target sequence, the Cas12a nuclease was activated to cleave a single-stranded DNA-fluorophore quencher (ssDNA-FQ) reporter, generating a fluorescent signal detectable either by a fluorescence detector or via visual readout. The entire procedure was performed at 37 °C and completed within one hour. The assay achieved a detection limit as low as 10 copies/µL and showed no cross-reactivity with other major porcine viruses. Furthermore, a rapid-release reagent was used to replace conventional DNA extraction from serum samples, facilitating efficient on-site detection. The assay was validated using clinical samples, and the results showed strong concordance with those obtained by PCR.
conclusionsThe RPA-CRISPR-based assay developed in this study is highly sensitive and specific, enabling detection of PCV2 within one hour. Its simplicity, rapidity, and ease of use in the field offer significant practical advantages, making it a valuable tool for the on-site diagnosis of PCV2. This method represents a promising alternative for the early and rapid detection of PCV2 infections and holds potential for contributing to the prevention and control of the disease in the swine industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.